Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
QDEL
SellBargain BinQuidelOrtho Corporation · Healthcare · United States · $1.0B · Avg Vol: $19M/d
COMPANY DESCRIPTION
QuidelOrtho Corporation is a global diagnostic company that develops, manufactures, and markets innovative diagnostic solutions for point-of-care, laboratory, and transfusion medicine applications. Its competitive moat is built upon a broad portfolio of proprietary diagnostic platforms, extensive R&D capabilities, and established global distribution channels, particularly in infectious disease testing and clinical labs. Formed from a significant merger, QuidelOrtho is a major player offering critical diagnostic tools to healthcare systems worldwide.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 3.3B | 3.0B | 2.8B | 2.7B | -5.8% | 2.7B | 2.5B | 2.6B | -2.6% |
| EPS | 16.74 | 9.66 | -0.15 | -30.16 | -16.69 | -42.3% | -15.43 | — | — | — |
| Shares | — | 66.4M | 66.7M | 67.3M | 67.9M | +2.3% | 68.6M | — | — | — |
| Debt | — | 2.8B | 2.6B | 2.7B | 2.8B | -0.2% | 3.1B | — | — | — |
| Equity | — | 4.9B | 5.0B | 3.0B | 1.9B | -27.0% | — | — | — | — |
| Op CF | — | 885.3M | 280.2M | 83.0M | 105.2M | -50.8% | -57.2M | — | — | — |
| Inv CF | — | -1.6B | -187.6M | -149.9M | -192.7M | — | — | — | — | — |
| Fin CF | — | 252.0M | -265.8M | 48.8M | 155.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of QDEL are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| QDEL | QuidelOrtho Corporation(you) | $1.0B | 29 | Sell |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.1B | 28 | Sell |
| CBLL | CeriBell, Inc. | $911M | 27 | Sell |
| BBNX | Beta Bionics, Inc. | $887M | 27 | Sell |
| ATEC | Alphatec Holdings, Inc. | $1.5B | 27 | Sell |
| TNDM | Tandem Diabetes Care, Inc. | $1.5B | 31 | Sell |
| AORT | Artivion, Inc. | $1.3B | 36 | Hold |
| CTKB | Cytek Biosciences, Inc. | $608M | 32 | Sell |
| SENS | Senseonics Holdings, Inc. | $493M | 29 | Sell |
| AHCO | AdaptHealth Corp. | $772M | 41 | Hold |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.3%